MAY 30, 2013 12:00 PM PDT

Companion Diagnostics Co-Development: Are you ready?

Speakers
  • Senior Staff Scientist, Medical Sciences R&D, Life Technologies
    Biography
      Janice Au-Young is a Senior Staff Scientist for Companion Diagnostics in the Medical Sciences R&D group at Life Technologies. She has a Ph.D. degree in Microbiology from the University of California, Davis and has performed post-doctoral research at NIH, MIT and UCSF. She has held senior positions working on target and biomarker identification in other leading genomic companies. Janice has been at Life Technologies since 2006 working on platforms in gene expression, genotyping and mutation detection. Currently, her focus is on molecular diagnostics and defining Companion Diagnostics applications whether it is TaqMan qPCR, Capillary Electrophoresis sequencing, or Ion Torrent Next Gen Sequencing.
       

    Abstract:

    Development of a companion diagnostic can be critical to the success of a drug. Pharmaceutical companies are committing more and more of their efforts to discover and deliver targeted therapies especially in oncology. As the number of such drugs increases, there will be more and more demand for diagnostics which will predict which patients will benefit from which drug. Our Companion Diagnostics Partner Program is designed to help pharmas and biotechs by providing a breadth of assays and platforms that can be leveraged for the development of new diagnostics. Our genetic platforms include next gen sequencing, Sanger sequencing and qPCR. At Life Technologies, we are uniquely positioned to provide pharmas with flexible, strategic and cost-effective means to develop and commercialize drugs with companion diagnostics.  


    Show Resources
    You May Also Like
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    JUN 20, 2018 10:00 AM EDT
    C.E. CREDITS
    JUN 20, 2018 10:00 AM EDT
    DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    Loading Comments...